Pentafecta Outcomes of 230 Cases of Robotic-assisted Radical Prostatectomy with Bilateral Neurovascular Bundle Preservation.

Abstract:

AIM:We analyzed pentafecta outcomes [complication-free, continence, potency, negative surgical margins (NSM)], biochemical recurrence (BCR)-free] of 230 patients undergoing robotic-assisted radical prostatectomy (RARP) with bilateral neurovascular (NVB) preservation. PATIENTS AND METHODS:Patient outcomes (group I, cases 1-115; group II, cases 116-230) were assessed prospectively. Definitions were: continence, using no pads; potency, ability to achieve/maintain erections firm enough for sexual intercourse; positive surgical margin, presence of tumor tissue on inked specimen surface; and BCR, two consecutive PSA levels >0.2 ng/ml after RALP. RESULTS:The mean patient age was 62.5 years, mean PSA=8.62 ng/ml. The complication-free rate was 93.9% (216/230), continence rate 98.3% (226/230), potency 86.1% (198/230), NSM 77.0% (177/230) and BCR-free 92.6% (213/230). The trifecta rate (continence, potency, BCR-free) was 81.7% (188/230). The pentafecta rate was 60.4% (139/230). CONCLUSION:Pentafecta is the new standard of outcomes for RARP with bilateral NVB, with patient selection and reduced positive surgical margins attaining best outcomes.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Ou YC,Yang CK,Kang HM,Chang KS,Wang J,Hung SW,Tung MC,Tewari AK,Patel VR

subject

Has Abstract

pub_date

2015-09-01 00:00:00

pages

5007-13

issue

9

eissn

0250-7005

issn

1791-7530

pii

35/9/5007

journal_volume

35

pub_type

杂志文章
  • Cancer resistance as an acquired and inheritable trait.

    abstract:AIM:To induce cancer resistance in wild-type mice and detect if the resistance could be inherited to the progeny of the induced resistant mice. Furthermore to investigate the spectrum and immunology of this inherited cancer resistance. MATERIALS AND METHODS:Resistance to with live S180 cancer cells in BALB/c mice was ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Koch J,Hau J,Jensen HE,Rieneck K

    更新日期:2014-11-01 00:00:00

  • Effect of the progestagen Promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells.

    abstract::Using reverse transcriptase polymerase chain reaction amplification it was possible to detect the presence of oestrogen sulphatase mRNA in different hormone-dependent (MCF-7, T-47D) and hormone-independent (MDA-MB-231, MDA-MB-468) mammary cancer cell lines. The expression of this mRNA is significantly higher in T-47D ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pasqualini JR,Maloche C,Maroni M,Chetrite G

    更新日期:1994-07-01 00:00:00

  • The role of growth factors in central nervous system tumours.

    abstract::The role of growth factors in tumour growth and progression has increasingly been studied over the last few years. This review summarizes the available data and discusses their limitations as well as their potential influence on future therapeutic strategies. A large body of data suggests an important role of EGF, TGF...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Nieder C,Schlegel J,Andratschke N,Thamm R,Grosu AL,Molls M

    更新日期:2003-03-01 00:00:00

  • Altered calcium metabolism in patients on long-term bisphosphonate therapy for metastatic breast cancer.

    abstract:BACKGROUND:Bisphosphonates (BPs) are considered the standard of care in metastatic breast cancer (MBC) patients with bone metastases. Because the survival for these patients may be prolonged compared with those patients with visceral metastases, they may be prescribed BPs for several years. The effects of this long-ter...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Simmons C,Amir E,Dranitsaris G,Clemons M,Wong B,Veith R,Cole DE

    更新日期:2009-07-01 00:00:00

  • Recorded quadrant incidence of female breast cancer in Great Britain suggests a disproportionate increase in the upper outer quadrant of the breast.

    abstract:BACKGROUND:The upper outer quadrant (UOQ) of the breast is the most frequent site for incidence of breast cancer, but the reported disproportionate incidence in this quadrant appears to rise with year of publication. MATERIALS AND METHODS:In order to determine whether this increasing incidence in the UOQ is an artifac...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Darbre PD

    更新日期:2005-05-01 00:00:00

  • Pattern of IGF-1 variants' expression in human cancer cell lines using a novel q-RT-PCR approach.

    abstract:BACKGROUND/AIM:Although insulin-like growth factor-1 (IGF-1) is well-implicated in cancer biology, the potential roles of IGF-1 variants in different types of cancer are largely unknown. The aim of the present study was to in vitro characterize several human cancers for their IGF-1 variant expression patterns. MATERIA...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Christopoulos PF,Philippou A,Koutsilieris M

    更新日期:2015-01-01 00:00:00

  • Proliferative markers in diagnosis of thyroid tumors: a comparative study of MIB-1 and topoisomerase II-a immunostaining.

    abstract:BACKGROUND:The differential diagnosis of well-differentiated tumors of follicular cell origin remains a most problematic task in thyroid pathology. Therefore, various diagnostic/prognostic thyroid markers are currently being studied. The aim of our study was to evaluate the proliferative MIB-1 and topoisomerase II-alph...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ludvíková M,Holubec L Jr,Ryska A,Topolcan O

    更新日期:2005-05-01 00:00:00

  • Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: role of carcino-embryonic antigen in assessment of response.

    abstract:BACKGROUND:Therapy for patients with hepatic metastases from colorectal cancer (CRC) remains controversial and may be improved by regional oxaliplatin which proved to be effective when administered systemically to patients with advanced CRC. METHODS:During the current study, which aims to determine the maximum tolerat...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kern W,Beckert B,Lang N,Waggershauser T,Braess J,Schalhorn A,Hiddemann W

    更新日期:2000-11-01 00:00:00

  • Cyclosporin A Reversed Chemoresistance of a Patient with Pure Red Cell Aplasia Secondary to Thymoma.

    abstract:CASE REPORT:This case study reports on a patient who relapsed with thymoma (mixed type) nine years after tumor resection. After four courses of rescue chemotherapy (docetaxel and cisplatinum), the patient was further diagnosed with pure red cell aplasia. It was noticed that cyclosporin A (CsA), which was administered t...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11861

    authors: Li P,Du F,Gong Z,Hu B,Chi C,Chu H,Chen J

    更新日期:2017-08-01 00:00:00

  • The tyrosine kinase inhibitor AG490 inhibits growth of cancer cells and activates ERK in LS174T and HT-29 cells.

    abstract:BACKGROUND:The activity of tyrosine kinases, although strictly regulated in normal cells, is often disturbed in cancer cells. The inhibition of a tyrosine kinase could be a target for treating cancer. MATERIALS AND METHODS:The colon cancer cell lines LS174T and HT-29 and the lung cancer cell line NCI-H292 were used. T...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Saito K,Iwashita J,Murata J,Abe T

    更新日期:2006-03-01 00:00:00

  • Reversal of multidrug resistance in murine lymphoma cells by amphiphilic dihydropyridine antioxidant derivative.

    abstract:BACKGROUND:Multidrug resistance, the principal mechanism by which cancer cells develop resistance to chemotherapy drugs, is a major factor in the failure of many forms of chemotherapies. AIM:The aim of the study was to investigate the effect of K-2-11 on the reversal of multidrug resistance. MATERIALS AND METHODS:The...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Cindric M,Cipak A,Serly J,Plotniece A,Jaganjac M,Mrakovcic L,Lovakovic T,Dedic A,Soldo I,Duburs G,Zarkovic N,Molnár J

    更新日期:2010-10-01 00:00:00

  • MIB1 (Ki-67) expression in non-Hodgkin's lymphomas.

    abstract::The MIB1 monoclonal antibody which is used as a marker of cell proliferation was studied by immunohistochemistry on formalin-fixed and paraffin embedded biopsy specimens of lymph nodes in 40 high- and 46 lowgrade cases of non-Hodgkin's lymphomas (NHL) classified according to the Kiel classification. All cases were fou...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kalogeraki A,Tzardi M,Panagiotides I,Koutsoubi K,Bolioti S,Rontogianni D,Stefanaki K,Zois E,Karidi E,Darivianaki K,Delides G,Kanavaros P

    更新日期:1997-01-01 00:00:00

  • UGP in urogenital disorders: Egyptian experience.

    abstract::UGP (Urinary gonadotropin peptide) also know as urinary gonadotropin fragment (UGF) or the beta-core of hCG (c beta hCG), was identified as a peptide with a molecular weight of 10.5 kD, having the same amino acid sequence as the core section of the beta-subunit of human chorionic gonadotropin. UGP has been found in no...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: el-Ahmady O,Halim AB,Gad M,Walker R

    更新日期:1996-07-01 00:00:00

  • Secretory phospholipase A2 mediates human esophageal adenocarcinoma cell growth and proliferation via ERK 1/2 pathway.

    abstract:BACKGROUND/AIM:Secretory phospholipase-A2 (sPLA2) mediates growth and proliferation of human esophageal adenocarcinoma cells (HEAC). Two major molecular pathways of cancer growth regulation include extracellular signal-regulated kinase 1/2 (ERK 1/2) and protein kinase-B (AKT). Phospholipase enzymes have been demonstrat...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Sadaria MR,Yu JA,Meng X,Fullerton DA,Reece TB,Weyant MJ

    更新日期:2013-04-01 00:00:00

  • Predictive factors for recurrence and survival in hepatocellular carcinoma in South Korea.

    abstract:AIM:To evaluate the factors predicting for recurrence and to analyze survival of patients with hepatocellular carcinoma (HCC). PATIENTS AND METHODS:A total of 743 patients who were consecutively diagnosed and treated with HCC were retrospectively analyzed from January 2004 to December 2012 at our institution. We analy...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Jun CH,Sim DW,Kim SH,Hong HJ,Chung MW,Myoung E,Koh HR,Cho SB,Kim HS,Choi SK,Rew JS

    更新日期:2013-09-01 00:00:00

  • Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.

    abstract::CYFRA 21-1 was evaluated in 115 untreated patients with malignant pleural effusions (96 with primary lung cancer and 19 with non lung cancer) and 99 patients with benign pleural effusions. The levels of pleural fluid CYFRA 21-1 were from 1 to 385 times higher than those in serum, in all the examined patients. The mean...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Toumbis M,Rasidakis A,Passalidou E,Kalomenidis J,Alchanatis M,Orphanidou D,Jordanoglou J

    更新日期:1996-07-01 00:00:00

  • Vitamin D-24-hydroxylase in benign and malignant breast tissue and cell lines.

    abstract::Tissue-specific expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alpha-OHase) and vitamin D-hydroxylase (24-OHase) may act as the pivotal link between 25-hydroxyvitamin D3 (25(OH)D3) serum levels and the anticancer effects of 1,25-dihydoxyvitamin D3 (1,25(OH)2D3) and alternative splicing of the enzymes may regul...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Fischer D,Becker S,Cordes T,Bücker B,Diedrich K,Friedrich M,Salehin D,Thill M

    更新日期:2009-09-01 00:00:00

  • Synergistic effects of adriamycin and TALL-104 cell therapy against a human gastric carcinoma in vivo.

    abstract::The single and combined antitumor effects of adriamycin and a major histocompatibility complex non-restricted human cytotoxic T cell line (TALL-104) were evaluated in severe combined immunodeficient (SCID) mice engrafted subcutaneously with a biopsy sample from a patient with a highly metastatic gastric carcinoma. Che...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Cesano A,Visonneau S,Rovera G,Santoli D

    更新日期:1997-05-01 00:00:00

  • 5-FU split dose; a phase I/II and pharmacokinetic study of a different schedule of the Nordic regimen in advanced colorectal carcinoma.

    abstract:PURPOSE:Despite more than four decades of fluoro-pyrimidine treatment in different cancers, the optimal schedule is still not known. The plasma half-life of 5-fluorouracil (5-FU) is extremely short and continuous infusion has gained popularity. In this study we explored whether repeated bolus 5-FU injections could impr...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Berglund A,Carlsson G,Gustavsson B,Frödin JE,Ragnhammar P,Glimelius B

    更新日期:2003-03-01 00:00:00

  • Clinical experience of integrative cancer immunotherapy with GcMAF.

    abstract:BACKGROUND:Immunotherapy has become an attractive new strategy in the treatment of cancer. The laboratory and clinical study of cancer immunotherapy is rapidly advancing. However, in the clinical setting, the results of cancer immunotherapy are mixed. We therefore contend that cancer immunotherapy should be customized ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Inui T,Kuchiike D,Kubo K,Mette M,Uto Y,Hori H,Sakamoto N

    更新日期:2013-07-01 00:00:00

  • Phase II Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Unresectable Esophageal Cancer.

    abstract:BACKGROUND/AIM:We performed a phase II study of triple-drug combination chemoradiotherapy (DCF-R therapy), in which docetaxel was added to the standard chemoradiotherapy (cisplatin [CDDP]/5-fluorouracil [5-FU]) for unresectable advanced esophageal cancer. PATIENTS AND METHODS:Sixty-one patients with unresectable advan...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14256

    authors: Takahashi K,Osaka Y,Ota Y,Watanabe T,Iwasaki K,Tachibana S,Nagakawa Y,Katsumata K,Tsuchida A

    更新日期:2020-05-01 00:00:00

  • Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer.

    abstract::The role of combination chemotherapy regimens in the management of ovarian cancer patients with tumors resistant to platinum compounds has not yet been defined. This multicenter prospective phase II study evaluated the activity and toxicity of the docetaxel-plus-irinotecan combination in ovarian cancer patients whose ...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Polyzos A,Kosmas C,Toufexi H,Malamos N,Lagadas A,Kosmidis C,Ginopoulos P,Ziras N,Kandilis K,Georgoulias V

    更新日期:2005-09-01 00:00:00

  • Antisense-Snail transfer inhibits tumor metastasis by inducing E-cadherin expression.

    abstract::Carcinoma cell metastasis is mediated by increased mobility and invasiveness via epithelial-mesenchymal transition (EMT). Snail, a zinc-finger transcription factor, triggers EMT by directly repressing E-cadherin expression. In this study, the correlation between E-cadherin and Snail expression was investigated. In add...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Zhang A,Chen G,Meng L,Wang Q,Hu W,Xi L,Gao Q,Wang S,Zhou J,Xu G,Meng L,Ma D

    更新日期:2008-03-01 00:00:00

  • Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO).

    abstract::Recently we demonstrated that several flavonoids can inhibit the proliferation of certain human thyroid cancer cell lines. Among the flavonoids tested, apigenin and luteolin are the most effective inhibitors of these tumor cell lines. In the present study, we investigated the signal transduction mechanism associated w...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yin F,Giuliano AE,Van Herle AJ

    更新日期:1999-09-01 00:00:00

  • A change in promoter methylation of hMLH1 is a cause of acquired resistance to platinum-based chemotherapy in epithelial ovarian cancer.

    abstract:BACKGROUND:Acquired resistance to platinum-based chemotherapy (Pt-chemo) is a major problem for improving the prognosis for patients with advanced epithelial ovarian cancer (EOC). However, the molecular mechanism of acquired resistance to Pt-chemo is not well understood. MATERIALS AND METHODS:hMLH1 promoter methylatio...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Watanabe Y,Ueda H,Etoh T,Koike E,Fujinami N,Mitsuhashi A,Hoshiai H

    更新日期:2007-05-01 00:00:00

  • WNT Signaling Driven by R-spondin 1 and LGR6 in High-grade Serous Ovarian Cancer.

    abstract:BACKGROUND/AIM:R-spondins control WNT signaling and RSPO1 and LGR6, two of its receptors, are uniquely expressed at high levels in high-grade serous ovarian cancer (HGSOC). The aim of this study was to assess the interrelations between the expression of the RSPOs and LGRs in HGSOC and in the ovarian surface (OSE) and f...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14623

    authors: Lee S,Jun J,Kim WJ,Tamayo P,Howell SB

    更新日期:2020-11-01 00:00:00

  • Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells.

    abstract:BACKGROUND:Heterodimer cooperation between ErbB receptors has limited clinical usefulness of receptor tyrosine kinase inhibitors (TKIs), erlotinib and gefitinib in the treatment of cancer. However, combination treatment of TKIs with gamma-tocotrienol targets multiple ErbB receptors and significantly inhibit +SA murine ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bachawal SV,Wali VB,Sylvester PW

    更新日期:2010-02-01 00:00:00

  • In vivo model systems for assessing an anti-cancer drug: responses of autochthonous and transplanted prostate tumors to cyclophosphamide.

    abstract::Therapeutic effects of cyclophosphamide (CPA) were compared in L-W rats with (a) transplanted prostate adenocarcinomas (PAs), and (b) with induced autochthonous PAs. All rats, except controls, were treated by IP-administered CPA in slow-release silastic membranes (a) at time 0 after inoculation of transplanted PA cell...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pollard M,Luckert PH

    更新日期:1990-01-01 00:00:00

  • Molecular prognostic factors in locally irresectable rectal cancer treated preoperatively by chemo-radiotherapy.

    abstract:PURPOSE:The aim of this study was to determine the relationship between survival and value of molecular markers in the primary tumour in a group of patients with irresectable rectal cancer, treated with preoperative chemo-radiotherapy. MATERIALS AND METHODS:Immunohistochemistry for p53, p21, bcl-2 and Ki-67 was perfor...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Reerink O,Karrenbeld A,Plukker JT,Verschueren RC,Szabó BG,Sluiter WJ,Hospers GA,Mulder NH

    更新日期:2004-03-01 00:00:00

  • Radiotherapy alone and chemoirradiation in recurrent squamous cell carcinoma of the vulva.

    abstract:AIM:To evaluate the role of radiotherapy alone or combined with chemotherapy in the treatment of recurrent vulvar cancer, emphasising the prognostic factors and outcomes. MATERIALS AND METHODS:Twenty women with loco-regional recurrence of vulvar carcinoma were retrospectively reviewed. Eleven patients were managed wit...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Raffetto N,Tombolini V,Santarelli M,Valeriani M,Galla DA,Enrici RM

    更新日期:2003-05-01 00:00:00